Konings, I R H M <br/><br/>
The applicability of mTOR inhibition in solid tumors.  [electronic resource] 

 -  Current cancer drug targets  May 2009 
 - 439-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1873-5576 
<br/><br/><label>Standard No.: </label>10.2174/156800909788166556  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Division<br/>Cell Survival<br/>Clinical Trials as Topic<br/>Drug Resistance, Neoplasm<br/>Everolimus<br/>Gene Amplification<br/>Humans<br/>Neoplasms--blood supply<br/>Neovascularization, Pathologic--physiopathology<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein Kinases--genetics<br/>Sirolimus--analogs & derivatives<br/>TOR Serine-Threonine Kinases